$TXG
10X Genomics Inc Stock $txg

$txg Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000119312520052640 Filed on February 27, 2020

Income Statement

Concept	2019 Q4	2019 Q3	2019 Q2
Revenue	$75.29M	$61.21M	$55.82M
YoY Change	48.93%	67.2%	75.84%
Cost Of Revenue	$16.60M	$15.48M	$15.01M
YoY Change	11.41%	195.36%	226.22%
Gross Profit	$58.71M	$45.73M	$40.81M
YoY Change	64.66%	45.79%	50.08%
Gross Profit Margin	77.98%	74.71%	73.12%
Selling, General & Admin	$38.80M	$32.61M	$32.57M
YoY Change	44.24%	70.66%	53.64%
% of Gross Profit	66.09%	71.32%	79.81%
Research & Development	$27.90M	$22.21M	$18.03M
YoY Change	-47.46%	100.35%	58.19%
% of Gross Profit	47.52%	48.57%	44.19%
Depreciation & Amortization	$2.850M	$2.040M	$2.180M
YoY Change	220.22%	140.0%	0.46%
% of Gross Profit	4.85%	4.46%	5.34%
Operating Expenses	$66.80M	$54.82M	$51.18M
YoY Change	-39.6%	18.41%	56.98%
Operating Profit	-$8.093M	-$9.096M	-$10.36M
YoY Change	-89.2%	-39.09%	91.68%
Interest Expense	$800.0K	$708.0K	$695.0K
YoY Change	-300.0%	7.44%	-331.67%
% of Operating Profit
Other Income/Expense, Net	$200.0K	-$499.0K	-$448.0K
YoY Change	-300.0%	26.01%	124.0%
Pretax Income	-$7.000M	-$9.595M	-$10.81M
YoY Change	-90.73%	-37.41%	83.22%
Income Tax	$100.0K	$8.000K	$100.0K
% Of Pretax Income
Net Earnings	-$7.134M	-$9.603M	-$10.88M
YoY Change	-90.55%	-37.42%	83.66%
Net Earnings / Revenue	-9.48%	-15.69%	-19.49%
Basic Earnings Per Share
Diluted Earnings Per Share	-$73.96K	-$99.90K	-$116.2K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$424.2M	$427.4M	$56.00M
YoY Change
Cash & Equivalents	$424.2M	$427.4M	$61.04M
Short-Term Investments
Other Short-Term Assets	$8.000M	$7.300M	$4.100M
YoY Change
Inventory	$15.27M	$13.31M	$12.30M
Prepaid Expenses
Receivables	$33.37M	$26.15M	$26.80M
Other Receivables	$0.00	$0.00	$7.900M
Total Short-Term Assets	$480.8M	$474.1M	$107.2M
YoY Change	352.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.82M	$46.84M	$38.30M
YoY Change	338.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$23.94M	$1.778M	$10.00M
YoY Change	1134.4%
Total Long-Term Assets	$125.1M	$98.67M	$48.40M
YoY Change	592.06%
TOTAL ASSETS
Total Short-Term Assets	$480.8M	$474.1M	$107.2M
Total Long-Term Assets	$125.1M	$98.67M	$48.40M
Total Assets	$605.9M	$572.8M	$155.6M
YoY Change	387.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.03M	$11.96M	$9.400M
YoY Change	48.18%
Accrued Expenses	$30.00M	$19.50M	$20.50M
YoY Change
Deferred Revenue	$3.297M	$3.082M
YoY Change	37.66%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.882M	$7.383M	$4.900M
YoY Change	136.02%
Total Short-Term Liabilities	$63.05M	$48.24M	$43.20M
YoY Change	94.82%
LONG-TERM LIABILITIES
Long-Term Debt	$19.84M	$22.31M	$24.80M
YoY Change	-22.17%
Other Long-Term Liabilities	$1.925M	$951.0K	$72.30M
YoY Change	149.68%
Total Long-Term Liabilities	$21.76M	$23.26M	$97.10M
YoY Change	-17.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$63.05M	$48.24M	$43.20M
Total Long-Term Liabilities	$21.76M	$23.26M	$97.10M
Total Liabilities	$185.8M	$151.4M	$140.3M
YoY Change	83.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$262.4M	-$255.2M
YoY Change	13.52%
Common Stock	$682.5M	$676.8M
YoY Change	6012.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$420.1M	$421.4M	-$227.9M
YoY Change
Total Liabilities & Shareholders Equity	$605.9M	$572.8M	$155.6M
YoY Change	387.43%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	-$7.134M	-$9.603M	-$10.88M
YoY Change	-90.55%	-37.42%	83.66%
Depreciation, Depletion And Amortization	$2.850M	$2.040M	$2.180M
YoY Change	220.22%	140.0%	0.46%
Cash From Operating Activities	$6.700M	$14.53M	$13.40M
YoY Change	-113.14%	-380.5%	-166.24%
INVESTING ACTIVITIES
Capital Expenditures	-$6.580M	-$13.68M	-$22.51M
YoY Change	132.51%	2106.45%	590.49%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$6.580M	-$13.68M	-$22.51M
YoY Change	132.51%	2106.45%	590.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.110M	415.6M	60.00K
YoY Change	-103.09%	101275.61%	-99.91%
NET CHANGE
Cash From Operating Activities	6.700M	14.53M	13.40M
Cash From Investing Activities	-6.580M	-13.68M	-22.51M
Cash From Financing Activities	-1.110M	415.6M	60.00K
Net Change In Cash	-990.0K	416.5M	-9.050M
YoY Change	-94.48%	-7827.09%	-119.85%
FREE CASH FLOW
Cash From Operating Activities	$6.700M	$14.53M	$13.40M
Capital Expenditures	-$6.580M	-$13.68M	-$22.51M
Free Cash Flow	$13.28M	$28.21M	$35.91M
YoY Change	-127.57%	-718.64%	-311.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	547000
CY2018	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	33000
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5292000
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2600000
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	634000
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1673000
CY2019	txg	Increase Decrease In Accrued Contingent Liabilities IncreaseDecreaseInAccruedContingentLiabilities	30658000
CY2019	txg	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	5771000
CY2018	txg	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	1701000
CY2019	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	12730000
CY2018	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	3328000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-31251000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-112485000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7066000
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3905000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	13333000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	2658000
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-614000
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-251000
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	101000
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	455000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5284000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14747000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6699000
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3732000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3535000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2429000
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	251000
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	999000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4901000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2587000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34627000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76409000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42742000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6284000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42767000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6709000
CY2018	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	19512000
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	704000
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	11000000
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	11000000
CY2018	txg	Payments On Capital Lease Obligations PaymentsOnCapitalLeaseObligations	69000
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	410824000
CY2018	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	84830000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3766000
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1798000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	414590000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	105367000
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-45000
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-18000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	406405000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	22231000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70088000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47857000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	476493000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	2250000
CY2018	us-gaap	Interest Paid Net InterestPaidNet	1824000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	22000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4492000
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2260000
CY2019	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	243244000
CY2019Q4	us-gaap	Inventory Net InventoryNet	15270000
CY2018Q4	us-gaap	Inventory Net InventoryNet	8570000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33371000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28088000
CY2019Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	424166000
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	65080000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8033000
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4498000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48821000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11127000
CY2019Q4	us-gaap	Assets Assets	605923000
CY2018Q4	us-gaap	Assets Assets	124310000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13028000
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8792000
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12394000
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7047000
CY2019Q4	txg	Accrued Expensesand Other Liabilities Current AccruedExpensesandOtherLiabilitiesCurrent	24448000
CY2018Q4	txg	Accrued Expensesand Other Liabilities Current AccruedExpensesandOtherLiabilitiesCurrent	9941000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9882000
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4187000
CY2019Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	52327000
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	5008000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23935000
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1939000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	480840000
CY2018Q4	us-gaap	Assets Current AssetsCurrent	106236000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	63049000
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32362000
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	6436000
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	3052000
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3996000
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2553000
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4838000
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2965000
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	6154000
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3545000
CY2019Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	3767000
CY2018Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1203000
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2025000
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1571000
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1173000
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	741000
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	467000
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	804000
CY2019Q4	txg	Customer Deposits Liability Current CustomerDepositsLiabilityCurrent	1304000
CY2018Q4	txg	Customer Deposits Liability Current CustomerDepositsLiabilityCurrent	381000
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1087000
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	738000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3949000
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2947000
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19837000
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25489000
CY2019Q4	txg	Accrued Contingent Liabilities Noncurrent AccruedContingentLiabilitiesNoncurrent	68658000
CY2018Q4	txg	Accrued Contingent Liabilities Noncurrent AccruedContingentLiabilitiesNoncurrent	38000000
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	834000
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1102000
CY2019Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	16120000
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3329000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1091000
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	771000
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243244000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	682494000
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11165000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-262367000
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-231116000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-46000
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-37000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	420083000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-219987000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	605923000
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	124310000
CY2019Q4	us-gaap	Liabilities Liabilities	185840000
CY2018Q4	us-gaap	Liabilities Liabilities	101053000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	61033000
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	28661000
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	10560000
CY2019	us-gaap	Gross Profit GrossProfit	184860000
CY2018	us-gaap	Gross Profit GrossProfit	117652000
CY2017	us-gaap	Gross Profit GrossProfit	60525000
CY2019	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	83097000
CY2018	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	47537000
CY2017	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	32164000
CY2018	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	62363000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	130834000
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	87936000
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46736000
CY2019	us-gaap	Operating Expenses OperatingExpenses	215433000
CY2018	us-gaap	Operating Expenses OperatingExpenses	228416000
CY2017	us-gaap	Operating Expenses OperatingExpenses	78900000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-30573000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-110764000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-18375000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	2805000
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	1024000
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	308000
CY2019	us-gaap	Interest Expense InterestExpense	3079000
CY2018	us-gaap	Interest Expense InterestExpense	2409000
CY2017	us-gaap	Interest Expense InterestExpense	811000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-460000
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1634000
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-366000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31033000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-112398000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18741000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	218000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	87000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21000
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-9000
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-22000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	300000
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-300000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	100000
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	100000
CY2018Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	804000
CY2017Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	174000
CY2019	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	741000
CY2018	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1685000
CY2019	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1078000
CY2018	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1055000
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	467000
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4100000
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.80
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2019	us-gaap	Revenues Revenues	245893000
CY2018	us-gaap	Revenues Revenues	146313000
CY2017	us-gaap	Revenues Revenues	71085000
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3297000
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2395000
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-15000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31260000
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-112507000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18777000
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.80
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-8.40
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.62
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39091366
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13392273
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11587751
CY2019Q4	txg	Accrued Commissions Current AccruedCommissionsCurrent	2473000
CY2018Q4	txg	Accrued Commissions Current AccruedCommissionsCurrent	2299000
CY2017	txg	Commonstock Warrants Issued CommonstockWarrantsIssued	141099
CY2018Q1	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	150000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16112652
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	82467503
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Entity Registrant Name EntityRegistrantName	10x Genomics, Inc.
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001770787
CY2019	dei	Security12b Title Security12bTitle	Class A common stock
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2019Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0
CY2019Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2018Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	67904871
CY2018Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	67704278
CY2018Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	67704278
CY2018Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	242588000
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1100000000
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	96241596
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	96241596
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190955000
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14549801
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14549801
CY2019	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	1502000
CY2018	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	30580000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-186000
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-249000
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	137000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-18762000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4305000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1661000
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	149000
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5131000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1995000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	702000
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-33000
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3034000
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	3498000
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1317000
CY2018	txg	Increase Decrease In Accrued Contingent Liabilities IncreaseDecreaseInAccruedContingentLiabilities	38000000
CY2017	txg	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	1844000
CY2017	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-68000
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	118000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10699000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3756000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3756000
CY2017	txg	Payments On Capital Lease Obligations PaymentsOnCapitalLeaseObligations	393000
CY2017	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	19964000
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1092000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20583000
CY2017	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14000
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6114000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41743000
CY2017	us-gaap	Interest Paid Net InterestPaidNet	658000
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6000
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	250000
CY2019	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2012-07-02
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, disclosure of contingent liabilities, and the reported amounts of revenue and expense. These judgments, estimates and assumptions are used for, but not limited to, revenue recognition, inventory valuation and write-downs, loss contingencies, accounting for assets acquisitions and the valuation of stock-based compensation awards. The Company bases its estimates on various factors and information, which may include, but are not limited to, history and prior experience, the Company’s forecasts and future plans, current economic conditions and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources. To the extent there are material differences between the Company’s estimates and the actual results, the Company’s future consolidated results of operation may be affected. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q4	us-gaap	Gross Profit GrossProfit	35654000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	56133000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-15693000
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-5923000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-15345000
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-75524000
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentrations </div></div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to credit risk consist of cash equivalents and accounts receivable. The Company’s cash and cash equivalents are primarily held with a large financial institution in the United States and deposits exceed the Federal Deposit Insurance Corporation’s insurance limit. The Company’s debt is with this same financial institution. The Company performs periodic evaluations of the risks associated with its investments and the relative credit standing of this financial institution. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company performs ongoing credit evaluations of its customers’ financial condition. The Company does not require collateral from its customers but may require upfront payments from certain customers. The Company has not experienced significant credit losses to date. For the years ended December 31, 2019, 2018, and 2017, no single customer represented more than 10% of revenue. As of December 31, 2019 and December 31, 2018, no single customer<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>represented more than 10% of the Company’s outstanding accounts receivable. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Substantially all the Company’s long-lived assets are located in the United States. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.23
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.13
CY2018Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-5.40
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	424166000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65080000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47857000
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	52327000
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5008000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	66456000
CY2019	us-gaap	Default Longterm Debt Description Of Violation Or Event Of Default DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault	Immediately upon the occurrence and during the continuance of an event of default, including the noncompliance with the above covenants, the lender may increase the interest rate per annum by 5.0% above the rate that would be otherwise applicable; stop future loan advances; require the Company to deposit 105% of any undrawn letters of credit, or 110% if the letter of credit was denominated in a foreign currency; and take control over all assets collateralizing the loan and take necessary means to protect the collateral.
CY2019	txg	Debt Instrument Penal Interest Rate Spread DebtInstrumentPenalInterestRateSpread	0.050
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13333000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2658000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1661000
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	72121688
CY2019Q4	txg	License Fees Accrued Noncurrent LicenseFeesAccruedNoncurrent	16251000
CY2018	us-gaap	Other Noncash Expense OtherNoncashExpense	792000
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25000
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	425000
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	80000
CY2019	txg	Purchase Of Technology Licenses Under Financing Arrangement PurchaseOfTechnologyLicensesUnderFinancingArrangement	22099000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2019	us-gaap	Advertising Expense AdvertisingExpense	1500000
CY2018	us-gaap	Advertising Expense AdvertisingExpense	700000
CY2017	us-gaap	Advertising Expense AdvertisingExpense	200000
CY2018	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0
CY2018	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0
CY2019	us-gaap	Depreciation Depreciation	6700000
CY2018	us-gaap	Depreciation Depreciation	3800000
CY2017	us-gaap	Depreciation Depreciation	4300000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	22912000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-546000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22366000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	787000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-145000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	642000
CY2019Q1	us-gaap	Revenues Revenues	53578000
CY2019Q2	us-gaap	Revenues Revenues	55819000
CY2019Q3	us-gaap	Revenues Revenues	61207000
CY2019Q4	us-gaap	Revenues Revenues	75289000
CY2019Q1	us-gaap	Gross Profit GrossProfit	39613000
CY2019Q2	us-gaap	Gross Profit GrossProfit	40813000
CY2019Q3	us-gaap	Gross Profit GrossProfit	45727000
CY2019Q4	us-gaap	Gross Profit GrossProfit	58707000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-3636000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-10878000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-9603000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-7134000
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.33
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2018Q1	us-gaap	Revenues Revenues	27408000
CY2018Q2	us-gaap	Revenues Revenues	31744000
CY2018Q3	us-gaap	Revenues Revenues	36607000
CY2018Q4	us-gaap	Revenues Revenues	50554000
CY2018Q1	us-gaap	Gross Profit GrossProfit	23438000
CY2018Q2	us-gaap	Gross Profit GrossProfit	27194000
CY2018Q3	us-gaap	Gross Profit GrossProfit	31366000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	23804000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	12612000
CY2019Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	494000
CY2018Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	652000
CY2019Q4	txg	Shares Of Capital Stock Authorized SharesOfCapitalStockAuthorized	1200000000
CY2019	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-6517000
CY2018	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-23604000
CY2019	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-2958000
CY2018	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-4479000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2684000
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1631000
CY2019	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	101000
CY2018	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	41000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1032000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	421000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	10783000
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	19133000
CY2019	txg	Income Tax Reconciliation Acquisition Related Expenses IncomeTaxReconciliationAcquisitionRelatedExpenses	116000
CY2018	txg	Income Tax Reconciliation Acquisition Related Expenses IncomeTaxReconciliationAcquisitionRelatedExpenses	10143000
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	345000
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	63000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28878000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	31031000
CY2019Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	15961000
CY2018Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	10874000
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4131000
CY2019Q4	us-gaap	Purchase Obligation PurchaseObligation	6400000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	2766000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	1616000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71409000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55673000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4953000
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	460000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4169000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2692000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	118000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2241000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1359000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6410000
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	10800000
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	19300000
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2019	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q4	txg	Number Of Operating Segment NumberOfOperatingSegment	1
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1630000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1625000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1563000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1532000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1503000
CY2019Q4	txg	Finitelived Intangible Assets Amortization Expense Year Six FinitelivedIntangibleAssetsAmortizationExpenseYearSix	1500000
CY2019Q4	txg	Finitelived Intangible Assets Amortization Expense After Year Six FinitelivedIntangibleAssetsAmortizationExpenseAfterYearSix	13013000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	67876000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25210000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19055000
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14083000
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3497000
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2250000
CY2019Q4	txg	Long Term Debt Maturities Repayments In Year Three LongTermDebtMaturitiesRepaymentsInYearThree	12170000
CY2019Q4	txg	Long Term Debt Maturities Repayments Due LongTermDebtMaturitiesRepaymentsDue	34969000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	72979000
CY2019Q4	us-gaap	Contractual Obligation ContractualObligation	4200000
CY2019Q4	txg	Long Term Debt Maturities Repayments Next Twelve Months LongTermDebtMaturitiesRepaymentsNextTwelveMonths	11744000
CY2019Q4	txg	Long Term Debt Maturities Repayments In Year Two LongTermDebtMaturitiesRepaymentsInYearTwo	11055000
CY2019Q4	txg	Long Term Debt Maturity Repayment Of Interest Expense LongTermDebtMaturityRepaymentOfInterestExpense	4969000
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	30000000
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	281000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	29719000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9882000
CY2013Q4	txg	Operating Loss Carryforwards Limitation Amount OperatingLossCarryforwardsLimitationAmount	4800000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-96431000
CY2017	txg	Adjustments To Additional Paid In Capital Vesting Of Shares Including Early Exercise Of Options AdjustmentsToAdditionalPaidInCapitalVestingOfSharesIncludingEarlyExerciseOfOptions	112000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1661000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-15000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-112509000
CY2018	txg	Adjustments To Additional Paid In Capital Vesting Of Shares Including Early Exercise Of Options AdjustmentsToAdditionalPaidInCapitalVestingOfSharesIncludingEarlyExerciseOfOptions	256000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	150000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2658000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-22000
CY2019	txg	Adjustments To Additional Paid In Capital Vesting Of Shares Including Early Exercise Of Options AdjustmentsToAdditionalPaidInCapitalVestingOfSharesIncludingEarlyExerciseOfOptions	494000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13333000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9000
CY2019	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Each share of Class B common stock has the right to ten votes and each share of Class A common stock has the right to one vote per share.
CY2019Q4	txg	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Assets And Liabilities Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilitiesNet	1237000
CY2019Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	38561000
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	6800000
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3500000
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	6247000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7581000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6794000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	6947000
CY2019Q4	txg	Operating Leases Future Minimum Payments Due After Year Four OperatingLeasesFutureMinimumPaymentsDueAfterYearFour	45410000
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019Q2	dei	Entity Public Float EntityPublicFloat	0
CY2019	dei	Entity File Number EntityFileNumber	001-39035
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-5614458
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	6230 Stoneridge Mall Road
CY2019	dei	Entity Address Address Line2 EntityAddressAddressLine2	Pleasanton
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94588
CY2019	dei	City Area Code CityAreaCode	925
CY2019	dei	Local Phone Number LocalPhoneNumber	401-7300
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2018Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2019	txg	Operating Loss Carry Forwards Expiration Year OperatingLossCarryForwardsExpirationYear	2032
CY2019	us-gaap	Tax Credit Carryforward Limitations On Use TaxCreditCarryforwardLimitationsOnUse	50 percentage
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2019Q4	us-gaap	Finite Lived Intangible Assets Fair Value Disclosure FiniteLivedIntangibleAssetsFairValueDisclosure	22100000
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4946000
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	460000
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7000
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0
CY2019	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company generally provides a one-year warranty on its instruments.
CY2019Q4	txg	Accrued Legal Expenses Current AccruedLegalExpensesCurrent	4375000
CY2018Q4	txg	Accrued Legal Expenses Current AccruedLegalExpensesCurrent	1769000
CY2019Q4	txg	Accrued License Fees Current AccruedLicenseFeesCurrent	6183000
CY2019Q4	txg	Accrued Property And Equipment Current AccruedPropertyAndEquipmentCurrent	3885000
CY2018Q4	txg	Accrued Property And Equipment Current AccruedPropertyAndEquipmentCurrent	990000
CY2019	txg	Contract With Customer Liability Increase Excluding Revenue Recognized ContractWithCustomerLiabilityIncreaseExcludingRevenueRecognized	2884000
CY2019	dei	Trading Symbol TradingSymbol	TXG

Files In Submission

Name	View Source	Status
0001193125-20-052640-index-headers.html	Edgar Link	pending
0001193125-20-052640-index.html	Edgar Link	pending
0001193125-20-052640.txt	Edgar Link	pending
0001193125-20-052640-xbrl.zip	Edgar Link	pending
d849320d10k.htm	Edgar Link	pending
d849320dex231.htm	Edgar Link	pending
d849320dex311.htm	Edgar Link	pending
d849320dex312.htm	Edgar Link	pending
d849320dex321.htm	Edgar Link	pending
d849320dex322.htm	Edgar Link	pending
d849320dex43.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g849320g02a18.jpg	Edgar Link	pending
g849320g20w24.jpg	Edgar Link	pending
g849320g37f07.jpg	Edgar Link	pending
g849320g38s93.jpg	Edgar Link	pending
g849320g38t16.jpg	Edgar Link	pending
g849320g39g23.jpg	Edgar Link	pending
g849320g60x75.jpg	Edgar Link	pending
g849320g63i49.jpg	Edgar Link	pending
g849320g64x71.jpg	Edgar Link	pending
g849320g80x64.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
txg-20191231.xml	Edgar Link	completed
txg-20191231.xsd	Edgar Link	pending
txg-20191231_cal.xml	Edgar Link	unprocessable
txg-20191231_def.xml	Edgar Link	unprocessable
txg-20191231_lab.xml	Edgar Link	unprocessable
txg-20191231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TXG
10X Genomics Inc Stock $txg

2019 Q4 Form 10-K Financial Statement

#000119312520052640 Filed on February 27, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TXG 10X Genomics Inc Stock $txg

2019 Q4 Form 10-K Financial Statement

#000119312520052640 Filed on February 27, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TXG
10X Genomics Inc Stock $txg